email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1756 - 1770
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Shanghai's JW Therapeutics Acquires Hong Kong Cell Therapy Company
$5.00
Available
Tigermed, a China Clinical CRO, Seeks up to $1 Billion in Hong Kong IPO
$5.00
Available
Sunshine Guojian, a 3SBio Subsidiary, Plans $248 Million Shanghai STAR Board IPO
$5.00
Available
Junshi Bio Stages $692 Million IPO on Shanghai's STAR Board
$5.00
Available
Gland Pharma, a Fosun Subsidiary, Plans $650 Million IPO in India
$5.00
Available
BioAtla Closes $72.5 Million Round for Conditionally Active Biologics
$5.00
Available
Arctic Vision Raises $32 Million for Ophthalmology Drugs in China
$5.00
Available
Venus Medtech Acquires China Rights to Non-implant Heart Valve Treatment
$5.00
Available
BeiGene Raises $2 Billion in Private Placement; Amgen Participates
$5.00
Available
Ocumension Stages $184 Million HK IPO; Climbs 152% on First Day
$5.00
Available
Germany's Merck Opens Shanghai Collaboration Center
$5.00
Available
OBiO Raises $28 Million for Viral Vector CRO/CDMO Operations
$5.00
Available
Asieris Approved to Start Global Phase III Trials of Cervical Lesion Treatment
$5.00
Available
Zai Lab In-licenses NSCLC Candidate from Turning Point in $178 Million Deal
$5.00
Available
Evive Bio Reports Positive Late-Stage Results of Neutropenia Treatment
$5.00
Available